<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03130387</url>
  </required_header>
  <id_info>
    <org_study_id>IEldawa</org_study_id>
    <nct_id>NCT03130387</nct_id>
  </id_info>
  <brief_title>Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding</brief_title>
  <acronym>Niche</acronym>
  <official_title>Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prevalence of Cesarean Section Niche in women With Unexplained Abnormal Uterine Bleeding&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prevalence of Cesarean Section Niche as diagnosed by office hysteroscopy and transvaginal&#xD;
      sonography in women With Unexplained Abnormal Uterine Bleeding&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">April 20, 2017</completion_date>
  <primary_completion_date type="Actual">April 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Hysteroscopic examination for patients with AUB</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of cisarean section niche</measure>
    <time_frame>1 year</time_frame>
    <description>Prevalence of cisarean section niche in women complainig of unexplained abnormal uterine bleeding</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Cesarean Section; Dehiscence</condition>
  <condition>Abnormal Uterine Bleeding</condition>
  <arm_group>
    <arm_group_label>Office hysteroscopy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Examinatin with Office hysteroscope for women with abnormal uterine bleeding who had a history of previous cesarean section</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Office Hysteroscope</intervention_name>
    <description>Diagnosis of C.S niche in patients wit AUB by office hysteroscope</description>
    <arm_group_label>Office hysteroscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with a history of cesarean section who are complaining of abnormal uterine&#xD;
        bleeding with the following criteria :&#xD;
&#xD;
          -  Normal complete blood count apart from paramaters of anemia&#xD;
&#xD;
          -  Not using drugs affecting coagulation profile&#xD;
&#xD;
          -  Bleeding is not related to pregnancy&#xD;
&#xD;
          -  Not using intrauterine contraceptive devices or hormonal contraceptives&#xD;
&#xD;
          -  By ultrasonography : no abnormalities in the pelvis e.g benign or malignant tumors ,&#xD;
             ovarian cysts or tumors&#xD;
&#xD;
          -  No evidence of cervical abnormalities as cause of bleeding with cervical examination&#xD;
             or cervical smears&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any patient not fulfilling the inclusion criteria&#xD;
&#xD;
          -  If the patient refused the technique ( office hysteroscopy )&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Females only</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>April 22, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2017</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ahmed Elsayed Hassan Elbohoty</investigator_full_name>
    <investigator_title>Head of Early Cancer Detection Unit</investigator_title>
  </responsible_party>
  <keyword>Hytsteroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

